DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study

Carmelo Gurnari, Hideki Makishima, Arda Durmaz, Enrico Attardi, Ryunosuke Saiki, Álex Bataller, Guilherme Sapinho, Lukasz P. Gondek, Yasuhito Nannya, Steve Best, Pramila Krishnamurthy, Kar Lok Kong, Yoshiko Atsuta, Senji Kasahara, Kazuma Ohyashiki, Yasushi Miyazaki, Nobuhiro Kanemura, Nobuhiro Hiramoto, Francesco Versino, María Julia Montoro, Sara Torres‐Esquius, Andres Jerez Cayuela, Miguel López-Esteban, Carolina Martínez‐Laperche, Hussein Awada, Valeria Visconte, Courtney D. DiNardo, Maria Teresa Voso, Amy E. DeZern, Guillermo Garcia‐Manero, Austin Kulasekararaj, Jaroslaw P. Maciejewski, Seishi Ogawa